NLTX
Neoleukin Therapeutics
Halal Rating :
See Details
Last Price
$4.03
Last updated:
Market Cap
$33.06m
7D Change
5.77%
1 Year Change
20.75%
Company Overview
Industries
Exchange
NASDAQ
Next Earnings Date
Nov. 13, 2023
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmune disorders using protein design technology. The company is headquartered in Seattle, Washington.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| June 30, 2023 | $1.18m | $3.07m | $0.98 | $0.98 | 83.07% | 32.00% |
| March 31, 2023 | $0.76 | $15.13m | $0.94 | $0.93 | 125.17% | 6.15% |
| Dec. 31, 2022 | $0.81 | $14.25m | $0.82 | $0.82 | 101.24% | 5.73% |
Company Impact
Help us evaluate Neoleukin Therapeutics's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.